Exelixis Competitors and Similar CompaniesClear all
Exelixis's competitors and similar companies include Genocea Biosciences and Northwest Biotherapeutics.
 Genocea Biosciences Genocea Biosciences is a biopharmaceutical company developing T cell-directed vaccines and immunotherapies to treat infectious diseases and cancer. |  Northwest Biotherapeutics Northwest Biotherapeutics is a biotechnology company focused on developing and commercializing immunotherapy products to treat cancer. | ||
Founding Date | Founding Date 1994 | Founding Date 2006 | Founding Date 1998 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Alameda, US HQ | Locations Cambridge, US HQ | Locations Bethesda, US HQ |
Employees | Employees 1,14712% decrease | Employees 593% decrease | Employees 1721% increase |
Valuation ($) | Valuation ($) 8.2 b | Valuation ($) 5.7 k | Valuation ($) 349.5 m |
Financial | |||
Revenue (est.) | Revenue (est.) $2.3b (FY, 2025) | Revenue (est.) $1.6m (FY, 2021) | Revenue (est.) $1.4m (FY, 2025) |
Net income | Net income $782.6m (FY, 2025) | Net income ($33.2m) (FY, 2021) | Net income ($60.2m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 209.5m | Total funding raised $ 135.9m |
For sources of this data, please see the company profile
View Company Profiles
Genocea Biosciences
HQ
Cambridge, US
Employees
59↓ 3% decrease
Genocea Biosciences is a biopharmaceutical company developing T cell-directed vaccines and immunotherapies to treat infectious diseases and cancer.
View companyNorthwest Biotherapeutics
HQ
Bethesda, US
Employees
17↑ 21% increase
Northwest Biotherapeutics is a biotechnology company focused on developing and commercializing immunotherapy products to treat cancer.
View company